drugset / Trial / NCT02410590
Rocuronium + Sugammadex vs. Succinylcholine + Cisatracurium + Neostigmine/Atropine in Obese Participants (MK-8616-104)
RandomizedParallel-groupDouble-blind
Summary
The primary objective of this trial is to compare the preference between two strategies of neuromuscular blocking (NMB) / reversal in adult obese patients undergoing laparoscopic abdominal surgery: Rocuronium + Sugammadex versus Succinylcholine + Cisatracurium + Neostigmine/Atropine. This will be done evaluating the average verbal numerical scale (VNS) scores obtained from surgeons blinded to the drugs administered. The primary hypothesis is that the strategy "Rocuronium + Sugammadex" provides a better surgical visual field in obese participants undergoing laparoscopic abdominal surgery than the strategy "Succinylcholine + Cisatracurium + Neostigmine/Atropine" as measured by VNS scores.
Timeline
- Start
- 2015-07
- Primary completion
- 2016-10
- Completion
- 2016-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Atropine | Other / unclassified | 0.01 mg/kg | — |
| Comparator | Cisatracurium | Small molecule | — | — |
| Comparator | Neostigmine | Other / unclassified | 0.05 mg/kg | — |
| Subject | Rocuronium | Other / unclassified | — | — |
| Subject | Sugammadex | Other / unclassified | 4 mg/kg | Intravenous |
| Comparator | Suxamethonium | Other / unclassified | 1 mg/kg | — |
Indications
No indication recorded.